Medpace (MEDP) Short Interest Ratio & Short Volume $347.52 +10.17 (+3.01%) Closing price 04:00 PM EasternExtended Trading$341.77 -5.75 (-1.65%) As of 06:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Medpace Short Interest DataMedpace (MEDP) has a short interest of 1.15 million shares, representing 4.51% of the float (the number of shares available for trading by the public). This marks a -1.71% decrease in short interest from the previous month. The short interest ratio (days to cover) is 3.5, indicating that it would take 3.5 days of the average trading volume of 229,361 shares to cover all short positions.Current Short Interest1,150,000 sharesPrevious Short Interest1,170,000 sharesChange Vs. Previous Month-1.71%Dollar Volume Sold Short$382.06 millionShort Interest Ratio3.5 Days to CoverLast Record DateDecember 31, 2024Outstanding Shares31,082,000 sharesFloat Size25,490,000 sharesShort Percent of Float4.51%Today's Trading Volume211,412 sharesAverage Trading Volume229,361 sharesToday's Volume Vs. Average92% Short Selling Medpace? Sign up to receive the latest short interest report for Medpace and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartMEDP Short Interest Over TimeMEDP Days to Cover Over TimeMEDP Percentage of Float Shorted Over Time Medpace Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 12/31/20241,150,000 shares $382.06 million -1.7%4.5%3.5 $332.23 12/15/20241,170,000 shares $404.74 million +2.6%4.6%3.2 $345.93 11/30/20241,140,000 shares $388.32 million No Change4.5%3 $340.63 11/15/20241,140,000 shares $354.12 million +3.6%4.5%2.9 $310.63 10/31/20241,100,000 shares $345.64 million -0.9%4.3%3.2 $314.22 10/15/20241,110,000 shares $392.16 million -10.5%4.4%3.2 $353.30 9/30/20241,240,000 shares $413.91 million +32.9%4.9%3.7 $333.80 9/15/2024933,100 shares $328.14 million +8.0%3.7%3.2 $351.67 8/31/2024864,300 shares $307.06 million -9.6%3.4%3.2 $355.27 8/15/2024956,000 shares $367.40 million +18.2%3.8%3.9 $384.31 Get the Latest News and Ratings for MEDP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Medpace and its competitors with MarketBeat's FREE daily newsletter. 7/31/2024808,700 shares $309.34 million -2.9%3.2%3.3 $382.52 7/15/2024833,200 shares $370.34 million -15.6%3.3%3.4 $444.48 6/30/2024987,100 shares $406.54 million +15.6%3.9%4.7 $411.85 6/15/2024854,200 shares $336.48 million -8.5%3.4%4.2 $393.91 5/31/2024933,800 shares $360.76 million +3.5%3.7%4.4 $386.34 5/15/2024902,500 shares $366.31 million -4.3%3.5%3.8 $405.88 4/30/2024942,800 shares $366.14 million -4.2%3.7%3.3 $388.35 4/15/2024984,500 shares $381.14 million +4.0%4.0%3.7 $387.14 3/31/2024946,600 shares $382.57 million -1.8%3.8%3.8 $404.15 3/15/2024963,600 shares $382.32 million +2.8%3.9%3.9 $396.76 2/29/2024937,200 shares $372.56 million -10.7%3.8%3.9 $397.52 2/15/20241,050,000 shares $414.06 million -3.7%4.2%4.7 $394.34 1/31/20241,090,000 shares $317.82 million +6.9%4.6%6 $291.58 1/15/20241,020,000 shares $292.46 million -2.9%4.3%4.2 $286.73 12/31/20231,050,000 shares $321.86 million -19.2%4.4%4.2 $306.53 12/15/20231,300,000 shares $389.48 million +2.4%5.5%5 $299.60 11/30/20231,270,000 shares $343.81 million -0.8%5.3%4.4 $270.72 11/15/20231,280,000 shares $361.42 million +7.6%5.3%4.5 $282.36 10/31/20231,190,000 shares $288.78 million -2.5%5.1%4 $242.67 10/15/20231,220,000 shares $291.70 million +9.9%5.2%4.3 $239.10 9/30/20231,110,000 shares $268.76 million +11.4%4.8%4 $242.13 9/15/2023996,100 shares $278.89 million +6.2%4.3%3.5 $279.98 8/31/2023938,100 shares $253.54 million -5.8%4.0%2.8 $270.27 8/15/2023995,900 shares $264.17 million -9.5%4.2%2.8 $265.26 7/31/20231,100,000 shares $278.49 million -24.7%4.7%3.1 $253.17 7/15/20231,460,000 shares $355.09 million -9.3%6.2%3.8 $243.21 6/30/20231,610,000 shares $386.67 million -22.6%6.9%4.3 $240.17 6/15/20232,080,000 shares $458.87 million +5.1%8.9%5.4 $220.61 5/31/20231,980,000 shares $409.80 million -2.0%8.5%5.5 $206.97 5/15/20232,020,000 shares $425.98 million +3.6%8.7%5.7 $210.88Ignore every stock… (Ad)Stocks have been on a tear in 2024… And there’s plenty of great opportunities out there. But one expert says you should forget about EVERY stock for a moment and focus on an even bigger opportunity. The current GOLD supercycle You see, stocks are a dime a dozen for the most part… And, fortunately, they go up more than they go down. But every few decades, precious metals have a systematic supercycle that tends to dwarf the potential of just about anything else. The last time things aligned like this on gold it surged 536%We put together this handy gold guide for you (no cost) so you know what to look for 4/30/20231,950,000 shares $390.27 million +18.2%8.4%5.1 $200.14 4/15/20231,650,000 shares $317.03 million +6.5%7.0%4.5 $192.14 3/31/20231,550,000 shares $291.48 million +4.0%6.5%4.6 $188.05 3/15/20231,490,000 shares $265.13 million +23.1%6.3%4.7 $177.94 2/28/20231,210,000 shares $234.59 million -5.5%5.1%4.2 $193.88 2/15/20231,280,000 shares $266.24 million -19.5%5.4%4.4 $208.00 1/31/20231,590,000 shares $351.50 million -4.8%6.7%6.2 $221.07 1/15/20231,670,000 shares $381.70 million -0.6%7.0%4.5 $228.56 12/30/20221,680,000 shares $356.85 million -4.0%7.1%4.4 $212.41 12/15/20221,750,000 shares $360.17 million +6.7%7.4%4.4 $205.81 11/30/20221,640,000 shares $344.22 million +2.5%6.9%3.7 $209.89 11/15/20221,600,000 shares $362.51 million -18.4%6.7%3.6 $226.57 10/31/20221,960,000 shares $435.08 million -9.7%8.3%4.5 $221.98 10/15/20222,170,000 shares $332.14 million -1.4%9.2%5.4 $153.06 9/30/20222,200,000 shares $345.77 million +11.7%9.3%6.3 $157.17 9/15/20221,970,000 shares $298.40 million +9.4%8.3%5.8 $151.47 8/31/20221,800,000 shares $265.70 million -3.7%7.3%5.8 $147.61 8/15/20221,870,000 shares $341.26 million -1.1%7.4%5.9 $182.49 7/31/20221,890,000 shares $320.41 million -11.7%7.5%5.4 $169.53 7/15/20222,140,000 shares $322.52 million +1.9%7.8%5.8 $150.71 6/30/20222,100,000 shares $314.31 million -4.1%7.8%6.3 $149.67 6/15/20222,190,000 shares $302.26 million +19.7%8.0%6.7 $138.02 5/31/20221,830,000 shares $262.13 million +10.9%6.7%6 $143.24 5/15/20221,650,000 shares $230.22 million +24.1%6.0%5.3 $139.53 4/30/20221,330,000 shares $177.65 million +9.9%4.9%3.7 $133.57 4/15/20221,210,000 shares $191.30 million -9.7%4.4%3.4 $158.10 3/31/20221,340,000 shares $219.21 million -3.6%4.8%3.8 $163.59 3/15/20221,390,000 shares $203.54 million +20.9%5.0%4 $146.43 2/28/20221,150,000 shares $175.92 million +17.6%4.0%3.5 $152.97 2/15/2022978,300 shares $135.86 million +7.3%3.4%3.2 $138.87 1/31/2022911,500 shares $161.75 million +37.7%3.1%4.1 $177.46 1/15/2022661,800 shares $116.84 million -3.3%2.2%3.4 $176.55 12/31/2021684,000 shares $148.87 million -10.8%2.3%4.1 $217.64 12/15/2021766,500 shares $161.21 million +25.6%2.6%4.6 $210.32 11/30/2021610,100 shares $126.54 million -9.6%2.1%3.4 $207.41 11/15/2021675,000 shares $147.70 million -8.8%2.3%3.8 $218.81 10/29/2021740,400 shares $167.74 million -17.6%2.5%4.3 $226.55 10/15/2021898,300 shares $168.05 million +0.2%3.1%5.1 $187.08 9/30/2021896,900 shares $169.77 million +1.9%3.1%5.3 $189.28 9/15/2021879,900 shares $157.65 million +19.6%3.0%5.2 $179.17 8/31/2021735,900 shares $134.19 million +3.8%2.5%4.3 $182.35 8/13/2021709,100 shares $126.00 million +7.3%2.5%4.7 $177.69 7/30/2021661,000 shares $116.30 million +2.5%2.3%4 $175.94 7/15/2021644,900 shares $117.47 million +8.3%2.2%3.6 $182.15 6/30/2021595,600 shares $105.20 million -10.9%2.1%3.2 $176.63 6/15/2021668,100 shares $122.30 million -1.4%2.3%3.6 $183.05 5/28/2021677,300 shares $113.15 million -0.9%2.4%3.6 $167.06 5/14/2021683,700 shares $109.57 million -1.4%2.4%3.4 $160.26 4/30/2021693,400 shares $117.39 million -10.5%2.4%3.1 $169.29 4/15/2021774,800 shares $137.78 million -7.9%2.7%3.8 $177.83Ignore every stock… (Ad)Stocks have been on a tear in 2024… And there’s plenty of great opportunities out there. But one expert says you should forget about EVERY stock for a moment and focus on an even bigger opportunity. The current GOLD supercycle You see, stocks are a dime a dozen for the most part… And, fortunately, they go up more than they go down. But every few decades, precious metals have a systematic supercycle that tends to dwarf the potential of just about anything else. The last time things aligned like this on gold it surged 536%We put together this handy gold guide for you (no cost) so you know what to look for 3/31/2021841,400 shares $136.70 million -6.7%2.9%4.3 $162.47 3/15/2021901,300 shares $144.21 million +8.5%3.2%4.2 $160.00 2/26/2021830,500 shares $132.07 million -1.4%2.9%3.9 $159.02 2/12/2021842,300 shares $140.96 million +13.0%3.0%4 $167.35 1/29/2021745,700 shares $99.88 million +1.3%2.6%3.6 $133.94 1/15/2021736,200 shares $104.59 million -27.8%2.6%3.1 $142.07 12/31/20201,020,000 shares $140.62 million +2.3%3.5%4.2 $137.86 12/15/2020996,700 shares $140.38 million +32.1%3.6%4 $140.84 11/30/2020754,400 shares $93.63 million +11.2%2.7%2.2 $124.11 11/15/2020678,400 shares $79.86 million -16.8%2.5%1.9 $117.72 10/30/2020815,400 shares $91.01 million +25.8%3.0%2.3 $111.62 10/15/2020648,100 shares $82.22 million -6.2%2.4%1.6 $126.86 9/30/2020690,800 shares $77.20 million -43.8%2.5%1.7 $111.75 9/15/20201,230,000 shares $147.69 million -11.5%4.5%3 $120.07 8/31/20201,390,000 shares $180.41 million -14.7%5.1%4.4 $129.79 8/14/20201,630,000 shares $206.93 million -24.9%6.0%5.2 $126.95 7/31/20202,170,000 shares $258.99 million -16.9%8.2%6.8 $119.35 7/15/20202,610,000 shares $259.77 million -0.4%9.9%9.3 $99.53 6/30/20202,620,000 shares $236.38 million +0.8%10.0%9.5 $90.22 6/15/20202,600,000 shares $219.88 million +0.4%9.9%8.6 $84.57 5/29/20202,590,000 shares $244.11 million +0.4%9.8%7.1 $94.25 5/15/20202,580,000 shares $211.12 million -10.7%9.8%6.7 $81.83 4/30/20202,890,000 shares $243.71 million +1.4%10.7%7.8 $84.33 4/15/20202,850,000 shares $223.92 million +2.5%10.4%8.2 $78.57 3/31/20202,780,000 shares $233.02 million +16.0%10.1%8.4 $83.82 3/13/20202,396,400 shares $199.19 million +4.7%8.8%6.8 $83.12 2/28/20202,290,000 shares $141.57 million +0.4%8.4%9.8 $61.82 2/14/20202,280,000 shares $211.99 million -4.6%8.3%10.5 $92.98 1/31/20202,390,000 shares $240.15 million -2.5%8.7%11.1 $100.48 MEDP Short Interest - Frequently Asked Questions What is Medpace's current short interest? Short interest is the volume of Medpace shares that have been sold short but have not yet been closed out or covered. As of December 31st, traders have sold 1,150,000 shares of MEDP short. 4.51% of Medpace's shares are currently sold short. Learn More on Medpace's current short interest. What is a good short interest ratio for Medpace? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MEDP shares currently have a short interest ratio of 4.0. Learn More on Medpace's short interest ratio. Which institutional investors are shorting Medpace? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Medpace: Jane Street Group LLC, Wolverine Trading LLC, Walleye Capital LLC, PEAK6 Investments LLC, and Genus Capital Management Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Medpace? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.51% of Medpace's floating shares are currently sold short. Is Medpace's short interest increasing or decreasing? Medpace saw a decrease in short interest in the month of December. As of December 31st, there was short interest totaling 1,150,000 shares, a decrease of 1.7% from the previous total of 1,170,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Medpace's float size? Medpace currently has issued a total of 31,082,000 shares. Some of Medpace's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Medpace currently has a public float of 25,490,000 shares. How does Medpace's short interest compare to its competitors? 4.51% of Medpace's shares are currently sold short. Here is how the short interest of companies in the industry of "business services" compare to Medpace: Trip.com Group Limited (1.93%), IQVIA Holdings Inc. (1.73%), Reddit, Inc. (17.65%), CGI Inc. (0.84%), Corpay, Inc. (1.78%), AerCap Holdings (1.25%), Joint Stock Company Kaspi.kz (0.41%), Grab Holdings Limited (4.65%), ICON Public Limited (1.92%), GFL Environmental Inc. (2.74%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.83 billion), Charter Communications, Inc. ($3.77 billion), Reddit, Inc. ($2.98 billion), The Kroger Co. ($2.97 billion), International Paper ($2.64 billion), SoFi Technologies, Inc. ($1.99 billion), Rivian Automotive, Inc. ($1.93 billion), Onsemi ($1.81 billion), SoundHound AI, Inc. ($1.59 billion), and Moderna, Inc. ($1.57 billion). View all of the most shorted stocks. What does it mean to sell short Medpace stock? Short selling MEDP is an investing strategy that aims to generate trading profit from Medpace as its price is falling. MEDP shares are trading up $10.17 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Medpace? A short squeeze for Medpace occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of MEDP, which in turn drives the price of the stock up even further. How often is Medpace's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MEDP, twice per month. The most recent reporting period available is December, 31 2024. More Short Interest Resources from MarketBeat Related Companies TCOM Short Interest Data IQV Short Interest Data RDDT Short Interest Data GIB Short Interest Data CPAY Short Interest Data AER Short Interest Data KSPI Short Interest Data GRAB Short Interest Data ICLR Short Interest Data GFL Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MEDP) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredThis coin could surge during Trump’s first week in office.Juan has never had a losing trade on Bitcoin. And he booked gains of 312% on Chainlink … Now, he says one v...Weiss Ratings | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medpace Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Medpace With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MEDP Stock Alerts